Ezeibe, M.C.O., Ngene, A.A., Anene, I., Amechi, B., Olowoniyi, P., Eze, J.I. and Animoke, P.C. (2013) Direct Passive Hemagglutination Test for Rapid Quantification of Plasma Loads of the Human Immunodeficiency Virus. Health, 5, 1351-1354. http://dx.doi.org/10.4236/health.2013.59183

has been cited by the following article:

• TITLE: In Vivo Antiretroviral Effects of the Medicinal Synthetic Aluminum-Magnesium Silicate

  AUTHORS: Maduike C. O. Ezeibe, Ijeoma J. Ogbonna

  KEYWORDS: Clinical Trial, Medicinal Synthetic Aluminum-Magnesium Silicate (Nanoparticles), Cure for HIV/AIDS

  JOURNAL NAME: World Journal of AIDS, Vol.5 No.2, May 19, 2015

  ABSTRACT: Viral loads (copies of RNA per ml of plasma) of HIV/AIDS patients, who volunteered for clinical trial of the Medicinal synthetic Aluminum-magnesium silicate, were assessed, before and after they were treated. The treatment lasted 4 weeks, 8 weeks and 12 weeks respectively. A patient who could not access approved laboratory for viral load test on time, continued the treatmentfor 24 weeks. Following treatment with the medicine, mean viral load of HIV/AIDS patients reduced (P